CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Monday reported a loss of $4.7 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 13 cents per share.
For the year, the company reported that its loss widened to $26.7 million, or 81 cents per share.
The company's shares closed at 72 cents. A year ago, they were trading at $4.